Last updated: February 12, 2024
Sponsor: Brigham and Women's Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Chronic Pain
Pain
Treatment
Mindfulness-Oriented Recovery Enhancement: (MORE) group
Psychoeducation
Clinical Study ID
NCT06268522
2023P001582
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion criteria:
- age>18yo
- Chronic Low Back Pain as seen on medical history as well as score of >3 on pain visualanalog scale (VAS) at the start of experimental sessions.
- receiving prescription opioids for three or more months and planning to start taperingtheir opioids with their provider.
- willing to be randomized to one of the two behavioral treatment. Patients referred orself-referred to the study from an outside clinic will also be able to participate (wewill be in contact with their prescribing provider)
- able and willing to perform/tolerate pain procedures (e.g., QST)
- able to communicate fluently in English
- able to use a smartphone or laptop for the virtual therapy program
Exclusion
Exclusion criteria:
- Current illicit substance use (e.g marijuana use will be exempted) at screening orduring trial as verified by urine toxicology screen and/or self-report for allparticipants;
- Medical condition known to influence QST or participation in the MORE intervention;serious psychiatric condition;
- regular meditation practice
- cognitive impairment
- pregnancy
- lack of English fluency
- severe OUD
- inability to provide informed consent.
Study Design
Total Participants: 200
Treatment Group(s): 2
Primary Treatment: Mindfulness-Oriented Recovery Enhancement: (MORE) group
Phase:
Study Start date:
February 01, 2024
Estimated Completion Date:
June 30, 2024
Connect with a study center
Brigham and Women's Hospital
Chestnut Hill, Massachusetts 02467
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.